ApiFix

What ApiFix does

ApiFix Ltd. is a privately held Israeli medical device company headquartered in Yokneam Elit and a wholly-owned subsidiary of OrthoPediatrics Corp. (Nasdaq: KIDS). It develops and commercializes the ApiFix MID-C System, a posterior dynamic deformity correction device for the surgical treatment of adolescent idiopathic scoliosis (AIS). The implant is anchored unilaterally with three pedicle screws and features a rod with polyaxial joints that allow controlled motion while gradually correcting spinal curvature, positioning the procedure as a less invasive, motion-preserving alternative to traditional spinal fusion. The system is authorized by the FDA under a Humanitarian Device Exemption granted in August 2019 and is currently in its 4th-generation iteration with 1,100+ patients treated since the first procedure in April 2012.

ApiFix generates revenue through hardware sales of the MID-C System to hospitals and pediatric orthopedic surgical centers across the United States, with surgeons performing the procedure in 23 states. Its go-to-market relies on enterprise field sales targeted at pediatric orthopedic surgeons, supported by clinical evidence dissemination, surgeon training resources, and a surgeon locator tool that connects patients to credentialed providers. Reimbursement friction is mitigated through a Patient Access Program operated in partnership with PRIA Healthcare, which provides prior authorization and appeal support. As a subsidiary of OrthoPediatrics, ApiFix leverages the parent's pediatric orthopedic sales infrastructure and capital base rather than maintaining an independent commercial organization. The company's customer base spans individual pediatric spine surgeons and the hospitals where they practice, with the end-patient population defined by specific clinical criteria: AIS patients with single Lenke 1 or Lenke 5 curves, Cobb angles between 35-60 degrees that reduce to 30 degrees or less on side-bending imaging.

Name

ApiFix

Legal name

ApiFix Ltd.

Website

https://apifix.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

ApiFix Ltd., a wholly-owned subsidiary of OrthoPediatrics Corp., develops the FDA-approved MID-C System, a motion-preserving, non-fusion spinal implant for adolescent idiopathic scoliosis, selling directly to pediatric orthopedic surgeons and hospitals across the United States.

Ownership category

akta.pro rank

Product category

Spinal Implants (Pediatric Orthopedic Deformity Correction Devices)

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Spine Implants & Motion Preservation (Fusion/Disc/Interspinous) (HLAHAEAC)

Keywords

• Spinal deformity correction
• Minimally invasive implant
• Adolescent idiopathic scoliosis
• Motion-preserving spine device
• Pediatric orthopedic implant

Headquarters

HQ city

Misgav Dov

HQ country

Israel

HQ region

Middle East

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Operations, Marketing or Sales, Personnel

Revenue model

1. Medical Device Sales: ApiFix sells its MID-C System (implantable medical device) to hospitals and surgical centers where the procedure is performed. The revenue is generated through device sales for surgical implantation in AIS patients.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

ApiFix develops, manufactures, and commercializes the MID-C System (Minimally Invasive Deformity Correction System), a posterior dynamic deformity correction device for adolescent idiopathic scoliosis. The implant is a single rod with polyaxial joints anchored with three pedicle screws on the concave side of the spine, designed to correct scoliosis while preserving motion as an alternative to spinal fusion.

Product overview

ApiFix offers a single unified medical device product — the ApiFix MID-C System — a minimally invasive, non-fusion surgical treatment for adolescent idiopathic scoliosis (AIS). The system consists of a posterior dynamic deformity correction implant with three anchor points and an extending rod with polyaxial joints. ApiFix operates as a wholly-owned subsidiary of OrthoPediatrics Corp. and provides the device alongside a Patient Access Program for insurance support. The company does not offer a modular software platform; the offering is the implant system, surgical technique guidance, and associated clinical support services.

Differentiator

Problem solved

Functional benefit

Brands

• ApiFix: The ApiFix procedure is a motion-preserving, non-fusion surgical treatment for adolescent idiopathic scoliosis (AIS).
• The Internal Brace Option
• Refuse to Fuse

Products and services

• ApiFix MID-C System (Minimally Invasive Deformity Correction System) Posterior dynamic deformity correction device (medical implant) for adolescent idiopathic scoliosis (AIS). It is sold to hospitals and pediatric surgical centers for use by pediatric orthopedic spine surgeons in patients with progressive scoliotic curves, as a motion-preserving, minimally invasive alternative to spinal fusion.
• Patient Access Program (reimbursement/insurance support service) Service offering that helps surgical centers and their patients obtain reimbursement and insurance coverage for the MID-C System procedure, supporting adoption by reducing administrative and payer hurdles for hospitals.

Quantifiable outcome

• 1,100+ patients treated since 2012
• +6 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• PRIA HealthcarecoreImplementation/ SI/ Consulting PartnerPRIA Healthcare provides the ApiFix Patient Access Program designed to accelerate patient access to the ApiFix procedure. They assist with prior authorization and appeals submissions, focusing on medical necessity, clinical evidence, and supporting documentation. This is a no-cost service for patients and healthcare providers seeking support with insurance denials for the ApiFix procedure.

Scale indicators5 records

Recent moves7 records

Expansion highlights4 records

Direct peers

• SeaSpine: Spine-focused medical device company offering fusion and motion-preservation solutions to hospitals and surgeons; comparable to ApiFix in channel, customer, and product category — deformity/correction spine.
• NuVasive: Spine-focused medical device company with established motion-preservation and deformity-correction portfolios (now part of Globus Medical); competes with ApiFix in adult and adolescent spine hospitals.
• Globus Medical: One of the largest spine-focused medical device companies, with broad product portfolios in fusion, motion preservation, and deformity correction including scoliosis — directly comparable to ApiFix as a spine-implant competitor across the same hospital call points.
• Alphatec (ATEC Spine): Pure-play spine company developing surgical solutions for deformity and lateral approaches; closely parallels ApiFix in spine deformity product focus and surgeon-hospital go-to-market.
• OrthoPediatrics Corp. ApiFix's parent company and the leading pure-play pediatric orthopedic device company; operates the same pediatric-hospital GTM motion and provides the distribution infrastructure that underpins ApiFix's commercial model.
• WishBone Medical: Pediatric orthopedic device company offering a broad portfolio of implants for children's orthopedic conditions; shares ApiFix's pediatric-only positioning, hospital channel, and surgeon customer base.

Emerging players

• Carlsmed: Emerging patient-specific spine company pursuing personalized implants for spinal deformity and degenerative conditions; comparable to ApiFix as a smaller, technology-forward spine player targeting hospital deformity cases.

Broad incumbents

• Medtronic: Global medtech incumbent with a substantial spine business including deformity-correction and motion-preservation offerings, competing for the same hospital procurement budgets and spine surgeon relationships as ApiFix.
• Zimmer Biomet: Global orthopedic incumbent with a meaningful spine presence (including motion-preservation systems such as the Tether for vertebral body tethering), directly competing with ApiFix for AIS motion-preservation cases.
• Stryker: Diversified orthopedic and spine incumbent; through its K2M acquisition operates a dedicated spine franchise covering deformity and motion-preservation segments, overlapping with ApiFix's call point on hospital spine surgeons.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/ApiFix
• Facebookfacebook.com/ApiFix
• LinkedInlinkedin.com/company/apifix

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds4 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ApiFix